Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran

  • Ramezani, Mazaher (Molecular Pathology Research Center, Emam Reza University Hospital) ;
  • Abdali, Elham (Students Research Committee, Kermanshah University of Medical Sciences) ;
  • Khazaei, Sedigheh (Molecular Pathology Research Center, Emam Reza University Hospital) ;
  • Vaisi-Raygani, Asad (Department of Clinical Biochemistry, Kermanshah University of Medical Sciences) ;
  • Sadeghi, Masoud (Cancer Research Center, Kermanshah University of Medical Sciences)
  • Published : 2016.04.11
Download PDF
⟨ Previous Next ⟩

Abstract

The tumor suppressor p16 is a biomarker for transforming human papilloma virus (HPV) infections that can lead to contradictory results in skin carcinomas. The aim of this study was to evaluate p16 expression and HPV-16 infection in the cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). This case-control study was performed on paraffin blocks of BCCs and SCCs and normal skin (53, 36, and 44 cases, respectively), between 2006 to 2015. Initial sections for groups were stained with hematoxylin and eosin (H & E). Immunohistochemistry was performed for p16 expression and human papilloma virus type 16 (HPV-16) infection. Normal group was skin of mammoplasty specimens and normal skin tissue in the periphery of tumors. The mean age at diagnosis was 42.1, 61.7 and 71.4 years for normal, BCC and SCC groups, respectively. P16 positivity was more in SCC and BCC groups compared to normal group (P<0.05) and HPV was negative in all patients in three groups. Also, the mean age at diagnosis and P16-positivity were higher for the SCC group than the BCC group (P<0.005). In conclusion, in non-melanoma skin cancers (SCC and BCC), p16-positivity can be a prognostic factor but there is no correlation between HPV-16 and p16 in these tumors.

Keywords

References

  1. Alexander RE, Hu Y, Kum JB, et al (2012). p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Mod Pathol, 25, 1526-33. https://doi.org/10.1038/modpathol.2012.103
  2. Aumayr K, Susani M, Horvat R, et al (2013). P16INK4A immunohistochemistry for detection of human papilloma virus-associated penile squamous cell carcinoma is superior to in-situ hybridization. Int J Immunopathol Pharmacol, 26, 611-20. https://doi.org/10.1177/039463201302600305
  3. Bashir SA, Pandith AA, Yousuf A, et al (2010). Lack of p16 gene mutations in gastric cancers in Kashmir. Asian Pac J Cancer Prev, 11, 339-42.
  4. Bixofis RB, Sassi LM, Patussi C, et al (2014). Significance of p16 positive expression in oropharyngeal cancers. Asian Pac J Cancer Prev, 15, 10289-92
  5. Conscience I, Jovenin N, Coissard C, et al (2006). P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol, 16, 518-22.
  6. Escutia B, Ledesma E, Serra-Guillen C, et al (2011). Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects. J Eur Acad Dermatol Venereol, 25, 832-8. https://doi.org/10.1111/j.1468-3083.2010.03875.x
  7. Eshkoor SA, Ismail P, Rahman SA, Oshkour SA (2008). p16 gene expression in basal cell carcinoma. Arch Med Res, 39, 668-73. https://doi.org/10.1016/j.arcmed.2008.06.003
  8. Hodges A, Smoller BR (2002). Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol, 15, 1121-5. https://doi.org/10.1097/01.MP.0000032536.48264.D1
  9. Klussmann JP, Gultekin E, Weissenborn SJ, et al (2003). Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol, 162, 747-53. https://doi.org/10.1016/S0002-9440(10)63871-0
  10. Kumar R, Ghosh SK, Verma AK, et al (2015). p16 Expression as a surrogate marker for HPV infection in esophageal squamous cell carcinoma can predict response to neo-adjuvant chemotherapy. Asian Pac J Cancer Prev, 16, 7161-5. https://doi.org/10.7314/APJCP.2015.16.16.7161
  11. Lewis JS Jr, Thorstad WL, Chernock RD, et al (2011). p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol, 35, 774-8.
  12. Lomas A, Leonardi-Bee J, Bath-Hextall F (2012). A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol, 166, 1069-80. https://doi.org/10.1111/j.1365-2133.2012.10830.x
  13. Mokhtari M, Mesbah A, Rajabi P, et al (2009). Determination of the relationship between Basal cell carcinoma and human papilloma virus, based on immunohistochemistry staining method. Indian J Dermatol, 54, 225-8. https://doi.org/10.4103/0019-5154.55629
  14. Paolini F, Carbone A, Benevolo M, et al (2011). Human Papillomaviruses, p16INK4a and Akt expression in basal cell carcinoma. J Exp Clin Cancer Res, 30, 108. https://doi.org/10.1186/1756-9966-30-108
  15. Patil S, Rao RS, Amrutha N, Sanketh DS (2014). Analysis of human papilloma virus in oral squamous cell carcinoma using p16: An immunohistochemical study. J Int Soc Prev Community Dent, 4, 61-6. https://doi.org/10.4103/2231-0762.131269
  16. Payette MJ, Whalen J, Grant-Kels JM (2010). Nutrition and nonmelanoma skin cancers. Clin Dermatol, 28, 650-62. https://doi.org/10.1016/j.clindermatol.2010.03.033
  17. Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A (2014). Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev, 15, 8351-9. https://doi.org/10.7314/APJCP.2014.15.19.8351
  18. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998). Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol, 153, 1741-48. https://doi.org/10.1016/S0002-9440(10)65689-1
  19. Santos M, Montagut C, Mellado B, et al (2004). Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol, 23, 206-14. https://doi.org/10.1097/01.pgp.0000130108.03231.89
  20. Shayanfar N, Hosseini N, Panahi M, et al (1013). Detection of mucosal type human papillomavirus in cutaneous squamous cell carcinoma in Iran. Pathol Res Pract, 209, 90-4. https://doi.org/10.1016/j.prp.2012.10.010
  21. Smeets SJ, Hesselink AT, Speel EJ, et al (2007). A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer, 121, 2465-72. https://doi.org/10.1002/ijc.22980
  22. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, et al (2009). p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev, 35, 210-20. https://doi.org/10.1016/j.ctrv.2008.10.005
  23. Tufaro AP, Chuang JC, Prasad N, et al (2011). Molecular markers in cutaneous squamous cell carcinoma. Int J Surg Oncol, 2011, 231475.
  24. Zhu HL, Zou ZN, Lin PX, et al (2015). Malignant transformation rate and p53, and p16 expression in teratomatous skin of ovarian mature cystic teratoma. Asian Pac J Cancer Prev, 16, 1165-8. https://doi.org/10.7314/APJCP.2015.16.3.1165

Cited by

  1. Cutaneous Squamous Cell Carcinoma vol.24, pp.4, 2017, https://doi.org/10.1097/PAP.0000000000000157